Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 27;37(1):96-107.
doi: 10.1016/j.immuni.2012.07.006.

The NLRP12 inflammasome recognizes Yersinia pestis

Affiliations

The NLRP12 inflammasome recognizes Yersinia pestis

Gregory I Vladimer et al. Immunity. .

Erratum in

  • Immunity. 2012 Sep 21;37(3):588

Abstract

Yersinia pestis, the causative agent of plague, is able to suppress production of inflammatory cytokines IL-18 and IL-1β, which are generated through caspase-1-activating nucleotide-binding domain and leucine-rich repeat (NLR)-containing inflammasomes. Here, we sought to elucidate the role of NLRs and IL-18 during plague. Lack of IL-18 signaling led to increased susceptibility to Y. pestis, producing tetra-acylated lipid A, and an attenuated strain producing a Y. pseudotuberculosis-like hexa-acylated lipid A. We found that the NLRP12 inflammasome was an important regulator controlling IL-18 and IL-1β production after Y. pestis infection, and NLRP12-deficient mice were more susceptible to bacterial challenge. NLRP12 also directed interferon-γ production via induction of IL-18, but had minimal effect on signaling to the transcription factor NF-κB. These studies reveal a role for NLRP12 in host resistance against pathogens. Minimizing NLRP12 inflammasome activation may have been a central factor in evolution of the high virulence of Y. pestis.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Infection of mice with Y. pestis-pYtbLpxL is controlled by IL-18
(A) Survival of mice infected s.c. with 500 CFU of Yersinia pestis KIM1001 (C57Bl/6: n=8) or KIM1001-pYtbLpxL (C57Bl/6 and Tlr4−/− [TLR4 KO]: n=10) bacteria. (B) Mortality of animals infected s.c. with 500 CFU of KIM1001-pYtbLpxL (n= 7 for Ifnar−/− [IFNαβR KO], 8 for Il12b−/− [IL-12p40 KO], 10 for C57Bl/6, Il1r1−/− [IL-1R1 KO], Il18r1−/− [IL-18R KO],Il18−/− [IL-18 KO] and TLR4 KO). Statistical differences: TLR4, IL-18 or IL-18R vs IL-1R and other strains: p<0.002. IL-12p40, IL-18, IL-18R, TLR4 vs C57Bl/6: p<0.001. (C,D) Survival of mice deficient in (C) IL-1β (II1b−/−, IL1β KO) and IL-1R and (D) IL-18 infected s.c. with 500 CFU of KIM1001-pYtbLpxL (n=10 of each genotype). (E,F) Concentrations of spleen IL-1β and IL-18 from C57BL/6 mice infected i.v. with 500 CFU of KIM1001 or KIM1001-pYtbLpxL for 44 hours. (G) IL-1β in supernatants from BMDM stimulated with 10 m.o.i. (multiplicity of infection) of KIM5 or KIM5-pYtbLpxL for 6 hours, 50µg/ml of gentamicin was added to wells after 3 h.p.i. (H) Immunoblot of IL-1β in the combined lysates and supernatants of BMDM stimulated with 10 m.o.i. of Y. pestis KIM5, KIM5-pEcLpxL, KIM5-pYtbLpxL and 1 m.o.i. of Salmonella typhimurium. Both pro-IL-1β (upper band) and mature IL-1β (lower band) are shown. Representative experiments out of 3–5 performed are shown. P values = *<0.05, **<0.01, ***<0.001. Also see Figure S1 and Table S1.
Figure 2
Figure 2. NLRP12 is involved in host resistance to attenuated Y. pestis
(A,B) Survival of C57Bl/6 (circles) and (A) Nlrp3−/− (NLRP3 KO, squares) and (B) Nlrp12−/− (NLRP12 KO, squares) mice infected s.c. with 500 CFU of KIM1001-pYtbLpxL. (C)_Survival of C57BL/6 (circles), NLRP12 KO (squares) or TLR4 KO (triangle) mice (n=10 of each) infected i.p. with 500 CFU of S. typhimurium, p<0.003 (NLRP12 KO or WT vs TLR4 KO). Also see Figure S2.
Figure 3
Figure 3. NLRP12 mediates Y. pestis-induced release IL-1β and IL-18
(A) IL-1β released from neutrophil-enriched peritoneal cells from C57BL/6 (black bars), NLRP12 KO (gray bars) and Casp1−/− (Caspase-1 KO, white bars) mice. (B–I) IL-18 (B), IL-1β (C,E,F,G,H,I) and TNF (D,G) released from C57BL/6, NLRP12 KO, NLRP3 KO, ASC KO and caspase-1 KO BMDM (B–D); C57BL/6 and NLRP12 KO BMDM (E); C57BL/6 BMDM (F,G); or C57BL/6 and TLR4 KO BMDM (I). Infection with Yersinia strains occurred for 6 hours, with an addition of 50 µg/ml gentamicin to limit bacterial growth after 3 hours. Yersinia strains were added at 10 m.o.i., S. typhimurium at 1 m.o.i. Alum (130 µg/ml) stimulations (C,I) lasted 6 hours after priming for 3 hours with 10 ng/ml KIM5-YtbLpxL LPS. Shown are mean for triplicate cultures (with S.D.) in representative experiments out of 3 to 10 performed. P values = *<0.05, **<0.01, ***<0.001.Statistical comparisons are between wild type cells and multiple mutant cells (A-E,I), or between unstimulated and multiple bacterial strains (F). Also see Figure S3.
Figure 4
Figure 4. NLRP12 is necessary for optimal maturation of IL-1β and caspase-1 after infection with Y. pestis
(A-B,G) Q-PCR of (A) Nlrp12, (B) Nlrp3, or (G) Il1b from BMDM infected with 10 m.o.i. of Y. pestis KIM5 or KIM5-pYtbLpxL for (G) 4 hours or (A–B) 6 hours, with gentamicin addition after 3 hours. (C,E) FACS histograms showing active caspase-1 after FLICA staining with corresponding (D,F) percent positive cells of (C–D) bone marrow cells after 6 hour of challenge with 10 m.o.i. of Y. pestis strains (gentamicin added after 3 hrs) or (E–F) Ly6G or F4/80 positive splenocytes from mice infected with 500 CFU of KIM1001 or KIM1001-pYtbLpxL for 24 hours. Values from unstimulated cells are subtracted in D. LPS primed cells treated with nigericin (10 µM) served as a control (C,D). (H) Immunoblot for caspase-1 p10 or IL-1β p17 in supernatant or cell lysate from BMDM exposed for 10 hours to poly(dA:dT) (LPS primed as in Figure 3), KIM5 or KIM5-pYtbLpxL. Shown is a representative of 2 (E–G) or 3–5 (A–D, H, I) experiments. P values: *<0.05, **<0.01, ***<0.001. Also see Figure S4.
Figure 5
Figure 5. NLRP12 and IL-18 control infection with Y. pestis in vivo
(A) IL-18 in serum (ng/ml) of C57Bl/6 or NLRP12 KO mice infected i.v. with 500 CFU Y. pestis KIM1001 for 44 hours, normalized by bacterial loads (for each animal). n=5. (B–D) IL-18 or IL-1β in (B–C) spleen or (D) serum of WT or NLRP12 KO mice infected i.v. with 500 CFU KIM1001-pYtbLpxL for 44 hours. (B,C): uninfected mice: n=3, infected animals: n=8. (D): Uninfected mice: n=4), infected mice: n=5). (E) Spleen CFU of mice infected i.v. with either KIM1001 or KIM1001-pYtbLpxL (n=5). Horizontal lines indicate median values. (F) Histology of fixed H&E stained liver sections from (top) WT, (middle) NLRP12 KO, or (bottom) IL-18R KO mice infected i.v. with (left) KIM1001 or (right) KIM1001-pYtbLpxL for 44 hours. Stars represent bacterial clusters, arrows represent foci of inflammatory cells, primarily neutrophils. (G) Survival of C57Bl/6 (n=10), IL-18 KO and NLRP12 KO (n=8) mice with 10 CFU s.c. of KIM1001. (H) Spleen CFU or (I) spleen IL-1β of C57Bl/6 and NLRP3 KO infected for 44 hrs with 500 CFU i.v. of KIM1001-pYtbLpxL. Representative experiments out of 3 performed are shown. P values = *<0.05, **<0.001. Also see Figure S5.
Figure 6
Figure 6. NLRP12 induces IFNγ via IL-18 signaling
(A,B) Survival of mice, (A): C57Bl/6: n=10 and Ifnar1−/− × Ifngr1−/− (IFNαβR × IFNγR DKO): triangles, n=8, and (B) C57Bl/6: squares, n=10, IFNαβR KO: n=8, IFNγR KO: n=7, infected s.c. with 500 CFU of KIM1001-pYtbLpxL. (C–D) IFNγ in spleen homogenates from C57BL/6 and NLRP12 KO mice infected i.v. with 500 CFU of KIM1001-pYtbLpxL. Uninfected mice: n=3, infected mice C: n=8, D: n=5) Samples were harvested 46 hrs after infection. Horizontal lines indicate median values. Experiments shown are representative out of 3 performed. P values: *<0.05 **<0.001.

Similar articles

Cited by

References

    1. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004;20:319–325. - PubMed
    1. Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC, Woodford RM, Davis BK, Uronis JM, Herfarth HH, et al. NLRP12 Suppresses Colon Inflammation and Tumorigenesis through the Negative Regulation of Noncanonical NF-kappaB Signaling. Immunity. 2012;36:742–754. - PMC - PubMed
    1. Arthur JC, Lich JD, Ye Z, Allen IC, Gris D, Wilson JE, Schneider M, Roney KE, O’Connor BP, Moore CB, et al. Cutting edge: NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivity. J Immunol. 2010;185:4515–4519. - PMC - PubMed
    1. Averette KM, Pratt MR, Yang Y, Bassilian S, Whitelegge JP, Loo JA, Muir TW, Bradley KA. Anthrax lethal toxin induced lysosomal membrane permeabilization and cytosolic cathepsin release is Nlrp1b/Nalp1b-dependent. PloS one. 2009;4:e7913. - PMC - PubMed
    1. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009;183:787–791. - PMC - PubMed

Publication types

MeSH terms